Sponsor pipeline

Eleison Pharmaceuticals LLC. clinical trial pipeline

Get alerts when Eleison Pharmaceuticals LLC.'s trials change

1 active trials 1 recruiting 1 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-08

What changed in the last 30 days

2026-10-08
Primary completion pushed: 2026-06 → 2028-03
Completion pushed: 2026-12 → 2028-06
NCT01954992 Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer · Phase 3

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT01954992 Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma Recruiting 2026-10-07

Disease areas by active trials

Pancreatic Cancer (1)

Get alerts when Eleison Pharmaceuticals LLC.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free